tiprankstipranks
Trending News
More News >
Salarius Pharmaceuticals Inc (SLRX)
NASDAQ:SLRX
US Market

Salarius Pharmaceuticals (SLRX) Income Statement

Compare
520 Followers

Salarius Pharmaceuticals Income Statement

Last quarter (Q4 2024), Salarius Pharmaceuticals's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Salarius Pharmaceuticals's net income was $-1.46M. See Salarius Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 1.84M$ 5.23M
Gross Profit
$ 0.00$ -10.05K$ -6.68K$ 1.82M$ 5.23M
Operating Expenses
$ 5.73M$ 12.89K$ 22.98M$ 14.65M$ 12.84M
Depreciation and Amortization
$ 0.00$ 10.05K$ 6.68K$ 19.18K$ 18.06K
EBITDA
$ 0.00-$ -31.60M$ -12.75M$ -7.33M
Operating Income
$ 0.00-$ -31.84M$ -12.81M$ -7.79M
Other Income/Expenses
$ 0.00-$ 233.18K$ 44.69K$ 434.09K
Pretax Income
$ -5.58M-$ -31.61M$ -12.77M$ -7.35M
Net Income
$ -5.58M-$ -31.37M$ -12.70M$ -7.10M
Per Share Metrics
Basic EPS
$ -5.79$ 0.00$ -14.77$ -7.68$ -11.39
Diluted EPS
$ -5.79$ 0.00$ -14.77$ -7.68$ -11.39
Weighted Average Shares Outstanding
962.21K 3.26M 2.12M 1.65M 623.14K
Weighted Average Shares Outstanding (Diluted)
962.21K 3.26M 2.12M 1.65M 623.14K
Currency in USD

Salarius Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis